TATSIS OURANIA (SVP, CRO) sold 0.9% of their position (466.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $214.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2026ACC: 0000875320-26-000052
Officer· SVP, CRO
Since Oct 2019
-2.61K
Net shares
Net seller
$1.22M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
2.61K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.14K
Price / share
$468.41
Trade value
$1M
% of position
4.0%
2/10/2026
54.04K→51.90K
Common Stock
Direct
Shares
−466.00
Price / share
$460.43
Trade value
$214.56K
% of position
0.9%
2/11/2026
51.90K→51.44K
Total
Net shares
−2.61K
Net value
-$1.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −2.14K | $468.41 | $1M | 4.0% | 54.04K | 51.90K |
| Common Stock Direct | 2/11/2026 | S · Sale | −466.00 | $460.43 | $214.56K | 0.9% | 51.90K | 51.44K |
| Total | −2.61K | -$1.22M | ||||||
Derivative Transactions0
No derivative transactions reported